Words are very important to cancer patients, some people hang their hats on them and put their feet up, and some people google them until they are tied in a knot, still fraught with worry. Why can’t doctors just tell me in layman’s language? Easy answer ……. because it is not an exact science. Doctors are not robots (…… yet!), they are human beings just like us. Doctors have different views and they can have different interpretations of long standing terms ingrained in the annals of medicine. Some doctors have better patient communication. They don’t have crystal balls, but they do really care and sometimes that’s what matters more.
One of the main stumbling blocks I find is that ‘cancer language’ has fallen behind science. People live longer with cancer nowadays with some cancers being described as having a chronic illness. But the words used to describe the effect of treatment or prognosis has not kept up – thus we hear fairly antique phrases which just don’t fit modern medicine. In the context of NET, I tried to analyse and decode that – read my post “Cure vs Remission vs No Evidence of Disease (NED)“. I stuck to the ingrained words I referred to above.
My own example.
Sure, I was told stage IV and incurable – pretty standard description even today. But I had advanced cancer (and still do today) but you simply cannot compare me with a small localised stage 1 Grade 1 appendix tumour which was removed with curative intent and showed clear margins. The selection of appendix is not intentional, I could have picked other NET primary types known not to frequently metastasise. And yet people do try to make the exact comparison in my group – totally ignoring the heterogeneity of NETs.
I then started to write about words that have been used by my own oncologist during surveillance periods – “stable” which was later described as “reassuringly stable“. The addition of that adjective is meaningful, perhaps more than ‘stable’. But the kicker to some might be that he also talked about ‘evidence of disease’ which threw some of the readers who perhaps thought it an oxymoron – a figure of speech in which apparently contradictory terms appear in conjunction, i.e. How can I be stable but with evidence of disease (ED)? The easy answer is because the disease which is evident is not doing much. The hard bit is finding the right medical term which people understand. It was validation of the “Cure vs Remission vs No Evidence of Disease (NED) blog as the answer is probably in there but with a pragmatic approach to interpretation – Remission means that the signs and symptoms of your cancer are reduced. Remission can be partial or complete and Partial remission means the cancer is still there, but your tumour has gotten smaller, or you have less cancer throughout your body. A lot of people use NED (no evidence of disease) but when you look at Full Remission definition you can see complications there, albeit it does look like they are synonyms. And clearly, NED is not a match for ‘evidence of disease but stable’.
Perhaps my Oncologist read my blog and decided to spice it up a bit. In 2024, he then awarded me with the accolades of “No evidence of progressive disease” and “reassuringly stable” Now we’re talking as those words mean a lot to me!
One day, medical parlance ingrained in the annals of medicine might actually catch up with the reality of cancer in 2026.
Finally, don’t interpret this post as ‘gung ho’ on my part. My situation might change tomorrow or at my next surveillance checkpoint. I’ll cross that bridge if and when I get to it.



Disclaimer
I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me.
Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional.
Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.
Click here and answer all questions to join my private Facebook group
Please Share this post for Neuroendocrine Cancer awareness and to help another patient
The Classification, Grading and Staging of Neuroendocrine Neoplasms (incorporating WHO 2026 classification changes)March 11, 2024Patient Advocacy
Spotlight on Cushing's Syndrome in Neuroendocrine NeoplasmsJuly 16, 2026A spotlight on NENs – Syndromes- 16 years since diagnosis, I’m still here

I finally made 16 years since I was diagnosed on 26th July 2010. A milestone I was not certain at the time I would reach. However, as things progressed, as treatment was administered, and as I got used to living with Neuroendocrine Cancer, I eventually became more confident this was a possibility with the help […]
- Spotlight on Cushing’s Syndrome in Neuroendocrine Neoplasms
Intro Cushing’s syndrome is one of the most challenging hormonal complications seen in people with neuroendocrine neoplasms (NENs). It can be subtle, severe, or even life‑threatening — and it is often misunderstood. Many patients struggle for months or years before receiving a correct diagnosis, partly because the symptoms overlap with everyday conditions such as weight… Read more: Spotlight on Cushing’s Syndrome in Neuroendocrine Neoplasms - 14th July 2026 – Ronny Allan hits 3 million blog views!
Today, 14th July 2026, I can confirm the 3 million views milestone has been reached. MASSIVE THANKS to you guys for reading and sharing. When I first set up this blog in April 2014, it was just to help spread awareness (….and collect a few pennies) whilst I was walking the 84 miles of… Read more: 14th July 2026 – Ronny Allan hits 3 million blog views! - Spotlight: Zinc in Neuroendocrine Tumours (NETs)
Before you read thisThis information is designed to help you understand how vitamins work in the body and how certain NET-related factors might affect them. It is not a substitute for personalised medical advice. Every NET patient is different — tumour type, treatments, surgery, symptoms, and nutritional needs can vary widely. If you have… Read more: Spotlight: Zinc in Neuroendocrine Tumours (NETs) - Neuroendocrine Tumours – Iron
Disclaimer: This Spotlight provides general educational information about Iron. It is not a substitute for medical advice. Individual needs vary, particularly for those with conditions affecting digestion, absorption, or chronic blood loss. Always consult your medical team before making changes to supplements or nutrition. Before I knew I had metastatic Neuroendocrine Tumours, I was diagnosed… Read more: Neuroendocrine Tumours – Iron - Ronny Allan’s Newsletter covering June 2026
Headline – half yearly point bonus edition Summary of June 2026 on RonnyAllan.NET June was similar to the other months of this year but slightly down on the previous two months due to holiday. Still a strong blog performance. Other key targets met were three more editions of the Spotlight series on primary NET types (colon, thymic… Read more: Ronny Allan’s Newsletter covering June 2026 - Clinical Trials PRRT: From 177Lu to 225Ac: The DOTA-LM3 Antagonist Journey
Disclaimer:Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over… Read more: Clinical Trials PRRT: From 177Lu to 225Ac: The DOTA-LM3 Antagonist Journey - Clinical Study from the Australasian Gastro-Intestinal Trials Group (AGITG) STOPNET
Disclaimer:Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the… Read more: Clinical Study from the Australasian Gastro-Intestinal Trials Group (AGITG) STOPNET - SYHX2008: A New Self‑Injectable subcutaneous Long‑acting Octreotide on the Horizon for NETs
Disclaimer:Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the… Read more: SYHX2008: A New Self‑Injectable subcutaneous Long‑acting Octreotide on the Horizon for NETs - Small tumours – big impact
Many Neuroendocrine Tumours are small. Not my words but I first discovered the term in 2021 when reading the words of Dr Mark Lewis, Oncologist and NET Patient. He himself, was citing this term referencing back to giants in the world of NETs over many decades. There was a seminal lecture entitled “An Odyssey in… Read more: Small tumours – big impact - The Invisibility of Neuroendocrine Tumours (NET) – an awareness post by Ronny Allan
“Invisible cancer” typically refers to malignancies that evade early detection or disguise themselves as other common, non-life-threatening ailments. This term is very frequently associated with Neuroendocrine Tumours which are very often difficult to spot on standard imaging and blood tests. When I was diagnosed, I didn’t even feel ill. It was therefore a bit of… Read more: The Invisibility of Neuroendocrine Tumours (NET) – an awareness post by Ronny Allan - Spotlight on Ovarian Neuroendocrine Neoplasms
Disclaimer: The information in this Spotlight is provided for general information and education only. It is not intended to replace the advice of a qualified healthcare professional, nor to be used for diagnosis or treatment of any medical condition. Always discuss your individual situation, symptoms, test results, and treatment options with your own doctor… Read more: Spotlight on Ovarian Neuroendocrine Neoplasms
Discover more from Ronny Allan - Living with Neuroendocrine Cancer
Subscribe to get the latest posts sent to your email.








